146 related articles for article (PubMed ID: 27162291)
1. [Autoimmune diseases with the presence of anti-ku antibodies - analysis of three cases].
Wielosz E; Majdan M; Jeleniewicz R; Mazurek M
Wiad Lek; 2016; 69(1):24-6. PubMed ID: 27162291
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.
Cavazzana I; Ceribelli A; Quinzanini M; Scarsi M; Airò P; Cattaneo R; Franceschini F
Lupus; 2008 Aug; 17(8):727-32. PubMed ID: 18625650
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease.
Rigolet A; Musset L; Dubourg O; Maisonobe T; Grenier P; Charuel JL; Behin A; Herson S; Amoura Z; Benveniste O
Medicine (Baltimore); 2012 Mar; 91(2):95-102. PubMed ID: 22391471
[TBL] [Abstract][Full Text] [Related]
4. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
[TBL] [Abstract][Full Text] [Related]
5. [Anti-Ku antibodies. Study of prévalence and of clinical meaning].
Beyne-Rauzy O; Couret B; Fortenfant F; Adoue D
Rev Med Interne; 2004 Sep; 25(9):619-22. PubMed ID: 15363616
[TBL] [Abstract][Full Text] [Related]
6. Anti-Ku antibodies: Clinical, genetic and diagnostic insights.
Belizna C; Henrion D; Beucher A; Lavigne C; Ghaali A; Lévesque H
Autoimmun Rev; 2010 Aug; 9(10):691-4. PubMed ID: 20621654
[TBL] [Abstract][Full Text] [Related]
7. Clinical and serological associations of anti-Ku antibody.
Cooley HM; Melny BJ; Gleeson R; Greco T; Kay TW
J Rheumatol; 1999 Mar; 26(3):563-7. PubMed ID: 10090163
[TBL] [Abstract][Full Text] [Related]
8. Anti-Ku autoantibodies: series of 5 cases.
Gryga K; Milewski M; Zółciński M; Dyczek A; Musiał J
Pol Arch Med Wewn; 2009; 119(1-2):95-7. PubMed ID: 19341186
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
[TBL] [Abstract][Full Text] [Related]
10. An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome.
Senécal JL; Isabelle C; Fritzler MJ; Targoff IN; Goldstein R; Gagné M; Raynauld JP; Joyal F; Troyanov Y; Dabauvalle MC
Medicine (Baltimore); 2014 Nov; 93(24):383-394. PubMed ID: 25500708
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T
Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against Ku protein in sera from patients with autoimmune diseases.
Yaneva M; Arnett FC
Clin Exp Immunol; 1989 Jun; 76(3):366-72. PubMed ID: 2665976
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of antinuclear antibody tests in children.
McGhee JL; Kickingbird LM; Jarvis JN
BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
[TBL] [Abstract][Full Text] [Related]
14. International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis.
Lakota K; Thallinger GG; Sodin-Semrl S; Rozman B; Ambrozic A; Tomsic M; Praprotnik S; Cucnik S; Mrak-Poljsak K; Ceribelli A; Cavazzana I; Franceschini F; Vencovsky J; Czirják L; Varjú C; Steiner G; Aringer M; Stamenkovic B; Distler O; Matucci-Cerinic M; Kveder T
Arthritis Res Ther; 2012 Jan; 14(1):R2. PubMed ID: 22226402
[TBL] [Abstract][Full Text] [Related]
15. Case of diffuse cutaneous systemic sclerosis with anti-Ku and anti-centromere antibodies.
Ohashi S; Ueda-Hayakawa I; Isei T; Okamoto H
J Dermatol; 2013 Jul; 40(7):558-61. PubMed ID: 23663134
[TBL] [Abstract][Full Text] [Related]
16. Mixed connective tissue disease.
Prystowsky SD
West J Med; 1980 Apr; 132(4):288-93. PubMed ID: 7385833
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study.
Hetlevik SO; Flatø B; Rygg M; Nordal EB; Brunborg C; Hetland H; Lilleby V
Ann Rheum Dis; 2017 Jan; 76(1):159-165. PubMed ID: 27283334
[TBL] [Abstract][Full Text] [Related]
18. Childhood-Onset Anti-Ku Antibody-Positive Generalized Morphea with Polymyositis: A Japanese Case Study.
Kishi T; Miyamae T; Morimoto R; Ishiguro N; Hamaguchi Y; Fujimoto M; Nagata S; Yamanaka H
Pediatr Dermatol; 2015; 32(5):e224-5. PubMed ID: 26205636
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of anti-Ku antibodies].
Mimori T; Suwa A; Hama N
Nihon Rinsho; 1990 Feb; 48 Suppl():535-8. PubMed ID: 2113133
[No Abstract] [Full Text] [Related]
20. [Mixed connective tissue disease (Sharp syndrome)].
Lang H; Gläser V; Hourieh M
Z Gesamte Inn Med; 1980 Nov; 35(22):824-8. PubMed ID: 6970457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
